ESR1 and neoplasm: To further explore the possible factors associated with E-cad expression loss (negative/low expression), we performed logistic regression analyses of the clinical and pathological factors, including ER, PR, HER2, and Ki-67 expression, as well as the molecular subtypes, histological grade, nodal stage, tumor stage, and TNM stage.